Market entry strategy
Turn a European or Italian launch objective into a clear sequence of access, evidence and commercial priorities.
AccessiaMed Consulting supports Pharma, MedTech and Life Sciences companies with market entry, pricing, reimbursement, HTA positioning and adoption strategy — with a particular focus on Italy.
Evidence → Reimbursement → Regional access → Hospital adoption
For companies asking:
We work at the intersection of market access, commercial strategy and local healthcare reality, helping teams focus effort where it can change outcomes.
Turn a European or Italian launch objective into a clear sequence of access, evidence and commercial priorities.
Shape the pathway from value proposition to reimbursement strategy, stakeholder dialogue and negotiation readiness.
Identify the evidence, comparators and economic narrative needed to support credible access discussions.
Translate national strategy into regional, hospital, procurement and adoption actions that reflect how Italy really works.
Prioritise the institutions, clinicians, payers, procurement actors and decision-makers that influence access.
Bridge the gap between authorization, reimbursement and real uptake with a practical go-to-market roadmap.
A strong launch plan needs to anticipate reimbursement logic, regional variation, hospital pathways, procurement dynamics and stakeholder expectations.
See our Italy approachItaly combines national reimbursement with regional implementation, local procurement and hospital-level decision making. We turn that complexity into a usable plan.
Recommendations are designed around what teams need to do next: who to engage, what to prepare, where to focus and what to measure.
Focused advisory for companies that need experienced market access thinking without adding a large consulting structure.
We can help you identify access barriers, commercial opportunities and the practical actions required before launch, during market entry or when adoption is underperforming.
Discuss your project